Literature DB >> 19798026

Inflammation: canakinumab for the cryopyrin-associated periodic syndromes.

Sinisa Savic, Michael F McDermott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19798026     DOI： 10.1038/nrrheum.2009.195

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

2.  Use of canakinumab in the cryopyrin-associated periodic syndrome.

Authors:  Helen J Lachmann; Isabelle Kone-Paut; Jasmin B Kuemmerle-Deschner; Kieron S Leslie; Eric Hachulla; Pierre Quartier; Xavier Gitton; Albert Widmer; Neha Patel; Philip N Hawkins
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

3.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

Authors:  Laetitia Agostini; Fabio Martinon; Kimberly Burns; Michael F McDermott; Philip N Hawkins; Jürg Tschopp
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

4.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Authors:  Raphaela Goldbach-Mansky; Natalie J Dailey; Scott W Canna; Ana Gelabert; Janet Jones; Benjamin I Rubin; H Jeffrey Kim; Carmen Brewer; Christopher Zalewski; Edythe Wiggs; Suvimol Hill; Maria L Turner; Barbara I Karp; Ivona Aksentijevich; Frank Pucino; Scott R Penzak; Margje H Haverkamp; Leonard Stein; Barbara S Adams; Terry L Moore; Robert C Fuhlbrigge; Bracha Shaham; James N Jarvis; Kathleen O'Neil; Richard K Vehe; Laurie O Beitz; Gregory Gardner; William P Hannan; Robert W Warren; William Horn; Joe L Cole; Scott M Paul; Philip N Hawkins; Tuyet Hang Pham; Christopher Snyder; Robert A Wesley; Steven C Hoffmann; Steven M Holland; John A Butman; Daniel L Kastner
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

Review 5.  NOD-like receptors and inflammation.

Authors:  Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

6.  In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes.

Authors:  Helen J Lachmann; Philip Lowe; Sandra Daniela Felix; Christiane Rordorf; Kieron Leslie; Sheril Madhoo; Helmut Wittkowski; Stephan Bek; Nicole Hartmann; Sophie Bosset; Philip N Hawkins; Thomas Jung
Journal:  J Exp Med       Date:  2009-04-13       Impact factor: 14.307
  6 in total
  6 in total

1.  "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.

Authors:  C M Hedrich; N Bruck; D Paul; G Hahn; M Gahr; A Rösen-Wolff
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

Review 2.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

Review 3.  Inflammasome and IL-1beta-mediated disorders.

Authors:  Hal M Hoffman; Alan A Wanderer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

4.  Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS).

Authors:  Justin Gillespie; Rebeccah Mathews; Michael F McDermott
Journal:  J Inflamm Res       Date:  2010-01-19

Review 5.  Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Authors:  Peleg Rider; Yaron Carmi; Idan Cohen
Journal:  Int J Cell Biol       Date:  2016-12-19

Review 6.  A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy.

Authors:  Marie-Eve Brien; Virginie Gaudreault; Katia Hughes; Dexter J L Hayes; Alexander E P Heazell; Sylvie Girard
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.964
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.